Llwytho...
Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
Treatment with BRAF inhibitors such as vemurafenib or dabrafenib in patients with advanced BRAFV600 mutated melanoma has shown objective tumor responses in approximately half of the patients. However, the duration of responses is limited in a majority of these patients, with progression-free surviva...
Wedi'i Gadw mewn:
| Prif Awduron: | , |
|---|---|
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
SAGE Publishing
2016-01-01
|
| Cyfres: | Therapeutic Advances in Medical Oncology |
| Mynediad Ar-lein: | https://doi.org/10.1177/1758834015616934 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|